TCF7L2基因变异贡献1型糖尿病表型异质性
研究纳入810例新诊断自身免疫性1型糖尿病TrialNet参与者,中位年龄13.6岁,分析TCF7L2 rs4506565与rs7901695对胰岛自身抗体数目及口服葡萄糖耐量试验刺激后C肽和血糖的影响。携带rs4506565变异与诊断时表达单一而非多种自身抗体独立相关(OR 1.66),此关联仅在≥12岁组显著(OR 2.12),且与更高C肽曲线下面积和更低平均血糖曲线下面积独立相关。
要点
- TCF7L2 rs4506565变异与诊断时单一而非多种胰岛自身抗体独立相关(OR 1.66)。
- 该关联仅在≥12岁参与者中显著(n=504,OR 2.12), younger组不显著(n=306,P=0.73)。
- rs4506565变异独立关联更高C肽AUC(P=0.008)和更低平均血糖AUC(P=0.0127)。
核心结论
- 在新发1型糖尿病队列中,2型糖尿病相关TCF7L2变异与≥12岁者单一自身抗体、更高C肽AUC和更低OGTT血糖AUC相关,携带者诊断时免疫与代谢表型较轻,可能部分由2型糖尿病样致病机制驱动。
研究设计与样本
- 研究为TrialNet参与者分析,纳入有新诊断自身免疫性1型糖尿病且具备TCF7L2 rs4506565和rs7901695 SNP数据的参与者810例,中位年龄13.6岁(范围3.3-58.6岁)。
主要发现
- rs4506565变异是诊断时表达单一而非多种自身抗体的显著独立因素(OR 1.66,95%CI 1.07-2.57,P=0.024)。
- 交互分析显示该关联仅在≥12岁参与者中显著(n=504,OR 2.12,95%CI 1.29-3.47,P=0.003),在较年轻者中不显著(n=306,P=0.73)。
- rs4506565变异独立关联更高的C肽曲线下面积(P=0.008)和更低的平均血糖曲线下面积(P=0.0127)。
- rs7901695 SNP的结果与rs4506565相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The phenotypic diversity of type 1 diabetes suggests heterogeneous etiopathogenesis. We investigated the relationship of type 2 diabetes-associated transcription factor 7 like 2 (TCF7L2) single nucleotide polymorphisms (SNPs) with immunologic and metabolic characteristics at type 1 diabetes diagnosis. RESEARCH DESIGN AND METHODS: We studied TrialNet participants with newly diagnosed autoimmune type 1 diabetes with available TCF7L2 rs4506565 and rs7901695 SNP data (n = 810; median age 13.6 years; range 3.3-58.6). We modeled the influence of carrying a TCF7L2 variant (i.e., having 1 or 2 minor alleles) on the number of islet autoantibodies and oral glucose tolerance test (OGTT)-stimulated C-peptide and glucose measures at diabetes diagnosis. All analyses were adjusted for known confounders. RESULTS: The rs4506565 variant was a significant independent factor of expressing a single autoantibody, instead of multiple autoantibodies, at diagnosis (odds ratio [OR] 1.66 [95% CI 1.07, 2.57], P = 0.024). Interaction analysis demonstrated that this association was only significant in participants ≥12 years old (n = 504; OR 2.12 [1.29, 3.47], P = 0.003) but not younger ones (n = 306, P = 0.73). The rs4506565 variant was independently associated with higher C-peptide area under the curve (AUC) (P = 0.008) and lower mean glucose AUC (P = 0.0127). The results were similar for the rs7901695 SNP. CONCLUSIONS: In this cohort of individuals with new-onset type 1 diabetes, type 2 diabetes-linked TCF7L2 variants were associated with single autoantibody (among those ≥12 years old), higher C-peptide AUC, and lower glucose AUC levels during an OGTT. Thus, carriers of the TCF7L2 variant had a milder immunologic and metabolic phenotype at type 1 diabetes diagnosis, which could be partly driven by type 2 diabetes-like pathogenic mechanisms.
引用
- Redondo MJ, Geyer S, Steck AK, et al. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care. 2017. PMID: 29025879. doi:10.2337/dc17-0961
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。